Latest Diabetes mellitus type 2 Stories
WINSTON-SALEM, N.C., June 24, 2011 /PRNewswire-USNewswire/ -- New research shows that gastric bypass significantly reduces the inflammation associated with diseases including cancer and diabetes - more proof of the overall health benefits of such surgery beyond weight loss. The study appears online in advance of print publication in the peer-reviewed journal Surgery for Obesity and Related Diseases. "We're amassing evidence that weight loss is a very important part of changing the way the...
SAN DIEGO, June 24, 2011 /PRNewswire/ -- For several years, researchers have known that bariatric surgery can significantly reduce or even eliminate symptoms of type 2 diabetes and other metabolic diseases/disorders in many patients.(1,2,3,4) What has been unclear is why. Through the Metabolic Applied Research Strategy (MARS), Ethicon Endo-Surgery Inc. (EES), a global leader in surgical innovations, and its academic research partners are beginning to understand why this happens, and why...
RIDGEFIELD, Conn. and INDIANAPOLIS, June 24, 2011 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes. If adopted by the European Commission, linagliptin will be the only DPP-4 inhibitor approved at...
SAN DIEGO, June 22, 2011 /PRNewswire/ -- Join three medical experts for a special media briefing as they discuss the topic, "Insights Into Why Bariatric Surgery Improves Type 2 Diabetes For Many Patients." The briefing, sponsored by Ethicon Endo-Surgery, can be accessed either in-person or via online video cast. The briefing will explore why bariatric surgery affects type 2 diabetes, and why the most basic earlier assumptions about how bariatric surgery works are wrong. (Logo:...
IRVINE, Calif., June 22, 2011 /PRNewswire/ -- Allergan, Inc. (NYSE: AGN) today announced a new study published in the peer-reviewed journal Surgery for Obesity and Related Diseases that found the cost of a gastric banding weight-loss surgery procedure, such as Allergan's LAP-BAND® Adjustable Gastric Banding System, was offset by reductions in obesity-related medical costs within 2.25 years for surgery eligible patients with diabetes, and within four years of the procedure for all surgery...
INDIANAPOLIS, SAN DIEGO and WALTHAM, Mass., June 21, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), together with Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Alkermes, Inc. (Nasdaq: ALKS), announced today that the European Commission has granted marketing authorization to BYDUREON(TM) (exenatide 2 mg powder and solvent for prolonged release suspension for injection). BYDUREON, a glucagon-like peptide-1 (GLP-1) receptor agonist, is the first once-weekly treatment for type 2...
SAN DIEGO, June 20, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA® (exenatide) injection and SYMLIN® (pramlintide acetate) injection, and its investigational diabetes drug candidates BYDUREON(TM) (exenatide extended-release for injectable suspension) and exenatide once monthly at the 71st Scientific Sessions of the American Diabetes Association (ADA) being held in...
SAN DIEGO and WOODCLIFF LAKE, N.J., June 20, 2011 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today that lorcaserin data from the Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus) trial will be presented in poster sessions at the American Diabetes Association's (ADA) 71st Scientific Sessions in San Diego, California. The posters highlighted below will be displayed in the Poster Hall...
WINSTON-SALEM, N.C., June 17, 2011 /PRNewswire-USNewswire/ -- Each year more than 200,000 people with morbid obesity undergo gastric bypass surgery, but research shows that more than half of patients regain at least 20 percent of the weight lost. Even celebrities find it difficult to keep the pounds off after gastric bypass. TV personality Al Roker and singer Carnie Wilson both have detailed their battle with weight gain after surgery; Wilson's struggle has lasted for years. To help gastric...
RIDGEFIELD, Conn. and INDIANAPOLIS, June 15, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced Tradjenta(TM) (linagliptin) tablets are now available by prescription in pharmacies across the United States including Walgreens, CVS, Rite Aid and many leading chain and independent pharmacies. The U.S. Food and Drug Administration (FDA) approved TRADJENTA on May 2, 2011 as a prescription medication used along with diet and...
